[25-014160] NIH nhlbi DNA sequencing core requires needs reagents/kits in order to to run miseq, novaseqx plus, iseq, and NEXTSEQ1000.
Ended Awarded Last action
- Contract number
- 75N92025F00020
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $249,496
Award facts
- Contract value 100% obligated
- $249,495.58 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$265 | |
| Other Administrative Action | $0 | |
| Original award | $249,760 |
About this award
The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order valued at $249,495.58 to Illumina, Inc. for reagents and kits necessary to operate multiple DNA sequencing platforms within its core facility. The order covers consumables for the MiSeq, NovaSeq X Plus, iSeq, and NextSeq 1000 sequencing systems and is structured as a firm fixed-price contract with an ultimate completion date of February 28, 2026. This delivery order was issued under an existing contract vehicle, enabling the NHLBI's San Diego-based core facility to procure essential reagents and supplies from the specialized biotechnology manufacturer that produces these proprietary sequencing instruments. No set-aside designation was applied to this award.
Illumina, Inc., headquartered in San Diego, California, is a established biotechnology company that serves as the primary federal supplier of next-generation sequencing platforms and associated consumables across multiple civilian and defense agencies. The company's extensive federal contracting portfolio includes a $45 million indefinite delivery contract with the U.S. Department of Agriculture through June 2030, numerous task orders and delivery orders from the National Institutes of Health, Department of Veterans Affairs, and other federal agencies, and specialized contracts supporting genomic research, diagnostics, and infectious disease surveillance. The firm fixed-price structure of this NHLBI delivery order reflects Illumina's position as the sole viable source for proprietary sequencing reagents and consumables, allowing the institute to maintain continuous operations of its DNA sequencing core facility supporting the NHLBI's cardiovascular, pulmonary, and hematological research missions.
Quick answers
Who was awarded contract 75N92025F00020?
75N92025F00020 was awarded to Illumina, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 19, 2025.
How much is contract 75N92025F00020 worth?
The government has obligated $249,496 on 75N92025F00020.
Is contract 75N92025F00020 an order under another contract?
Yes. 75N92025F00020 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N92025F00020 competed?
The extent of competition for 75N92025F00020 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award